Rondo Benetto
Investor Relations
Replay available
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) Q3 2025 earnings conference call, held 2025-10-28. Replay captured from the company's public earnings webcast.

Investor Relations
Chairman
Chief Financial Officer
VP Marketing
Analyst, Oppenheimer
Analyst, Needham & Company
Analyst, Craig-Hallum Capital
Analyst, TD Securities (on behalf of Krish Sankar)
Chief Executive Officer
Ladies and gentlemen, and welcome to UCT Q3 2025 Financial Results Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call, you require immediate assistance, please press star zero for the operator. Please be advised that this call is being recorded on Tuesday, October 28, 2025. I will now turn the call over to our first speaker today, Rondo Benetto, Investor Relations. Please go ahead. Thank you, Operator. Good afternoon, everyone, and thank you for joining us. With me today are Clarence Granger, Chairman, James Zhao, CEO, Sherry Savage, CFO, and Cheryl Knepler, VP Marketing. Clarence will begin with some prepared remarks about the quarter, and James will share his thoughts on the industry and the opportunities ahead for UCT. Sherry will follow with a financial review, and then we'll open up the call for questions. Today's call contains forward-looking statements that are subject to risks and uncertainties. For more information, please refer to the Risk Factors section in our SEC filings. All forward-looking statements are based on estimates, projections, and assumptions as of today, and we assume no obligation to update them after this call. Discussion of our financial results will be presented on a non-GAAP basis. A reconciliation of GAAP to non-GAAP can be found in today's press release posted on our website. And with that, I would like to turn the call over to Clarence. Clarence? Thank you, Rhonda. And good afternoon, everyone. We appreciate you joining our third quarter 2025 conference call. I'll start with a brief review of our Q3 results, followed by an update on our three areas of focus, including new product introduction, flattening the organ...